Sitryx presents new preclinical data highlighting PKM2 as a promising metabolic target for the treatment of atopic dermatitis at the Inflammatory Disease Skin Sum…

Preclinical data highlight that PKM2 modulation inhibits several important mechanisms underlying atopic dermatitis ...